Roberts, Tim J M <br/><br/>
PPAR-gamma agonist rosiglitazone reverses increased cerebral venous hydraulic conductivity during hypertension.  [electronic resource] 

 -  American journal of physiology. Heart and circulatory physiology  Oct 2009 
 - H1347-53 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1522-1539 
<br/><br/><label>Standard No.: </label>10.1152/ajpheart.00630.2009  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antihypertensive Agents--pharmacology<br/>Antioxidants--pharmacology<br/>Blood Pressure--drug effects<br/>Brain Edema--etiology<br/>Capillary Permeability--drug effects<br/>Cerebral Veins--drug effects<br/>Cerebrovascular Circulation--drug effects<br/>Chronic Disease<br/>Cyclic N-Oxides--pharmacology<br/>Disease Models, Animal<br/>Female<br/>Hydrostatic Pressure<br/>Hypertension--chemically induced<br/>NG-Nitroarginine Methyl Ester<br/>PPAR gamma--agonists<br/>Rats<br/>Rats, Sprague-Dawley<br/>Rosiglitazone<br/>Spin Labels<br/>Thiazolidinediones--pharmacology<br/>Time Factors